The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Research

• Publication date

  2000-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11156367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amplification of the epidermal‐growth‐factor‐receptor gene correlates with different growth behaviour in human glioblastoma

  2007cited by this paper
• Zac1 (Lot1), a Potential Tumor Suppressor Gene, and the Gene for ɛ-Sarcoglycan Are Maternally Imprinted Genes: Identification by a Subtractive Screen of Novel Uniparental Fibroblast Lines

  2000cited by this paper
• The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes.

  2000cited by this paper
• Cancer-epigenetics comes of age

  1999cited by this paper
• Hypermethylation of the p16/CDKN2A/MTS1 gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas

  1999cited by this paper
• LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein

  1999cited by this paper
• Inhibition of Zac1, a New Gene Differentially Expressed in the Anterior Pituitary, Increases Cell Proliferation.

  1999influential reference
• Inhibition of Zac1, a new gene differentially expressed in the anterior pituitary, increases cell proliferation.

  1999cited by this paper
• Pathogenesis of pituitary tumors.

  1999influential reference
• Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors

  1999cited by this paper
• hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer.

  1998influential reference
• The cytogenesis and pathogenesis of pituitary adenomas.

  1998cited by this paper
• Identification of a zinc-finger gene at 6q25: a chromosomal region implicated in development of many solid tumors

  1997cited by this paper
• Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells.

  1997cited by this paper
• Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker.

  1997cited by this paper
• Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain

  1997influential reference
• A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer.

  1996cited by this paper
• Cell-specific expression of estrogen receptor in the human pituitary and its adenomas.

  1995influential reference
• Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth.

  1995cited by this paper
• Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.

  1993cited by this paper
• G-proteins and hormonal signalling in human pituitary tumors: genetic mutations and functional alterations.

  1993influential reference

• Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine

  2022cites this paper
• Association of Pathology Markers with Somatostatin Analogue Responsiveness in Acromegaly

  2022cites this paper
• Plagl1 is part of the mammalian retinal injury response and a critical regulator of Müller glial cell quiescence

  2021cites this paper
• The role of the aryl hydrocarbon receptor interacting protein in pituitary tumorigenesis

  2021cites this paper
• Potential markers of disease behavior in acromegaly and gigantism

  2020cites this paper
• Hypoxia and the hypoxia inducible factor 1α activate protein kinase A by repressing RII beta subunit transcription

  2020cites this paper
• Molecular determinants of the response to medical treatment of growth hormone secreting pituitary neuroendocrine tumors.

  2019cites this paper
• Geoffrey Harris Award 2019: Translational research in pituitary tumors.

  2019cites this paper
• Inhibition of Heat Shock Factor 1 Enhances Repressive Molecular Mechanisms on the POMC Promoter

  2019cites this paper
• Plag1 and Plagl2 have overlapping and distinct functions in telencephalic development

  2018cites this paper
• PLAGL1 gene function during hepatoma cells proliferation

  2018cites this paper
• PLAGL1: an important player in diverse pathological processes

  2017cites this paper
• Genetics of pituitary adenomas

  2017cites this paper
• 11 Control of Retinal Development by Tumor Suppressor Genes

  2017cites this paper
• Correlation between gastric carcinoma and ZAC gene-associated microsatellite instability and loss of heterozygosity.

  2017cites this paper
• Genetic Aspects of Pituitary Adenomas.

  2017cites this paper
• Identification of Plagl1/Zac1 binding sites and target genes establishes its role in the regulation of extracellular matrix genes and the imprinted gene network

  2017cites this paper
• AIP and the somatostatin system in pituitary tumours.

  2017cites this paper
• Novel molecular mechanisms involved in the pathogenesis of GH-secreting pituitary adenomas

  2016cites this paper
• Animal models of pituitary neoplasia

  2016cites this paper
• Molecular markers in pituitary tumors

  2016cites this paper
• Expression and Clinical Significance of miR-26a and Pleomorphic Adenoma Gene 1 (PLAG1) in Invasive Pituitary Adenoma

  2016cites this paper
• Molecular genetic advances in pituitary tumor development

  2015cites this paper
• Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.

  2015cites this paper
• Altered expression of the PLAGL1 (ZAC1/LOT1) gene in colorectal cancer: Correlations to the clinicopathological parameters.

  2015cites this paper
• Mammalian Ste20-like kinase 4 promotes pituitary cell proliferation and survival under hypoxia.

  2015cites this paper
• Ageing in the mammalian brain

  2015cites this paper
• Capítulo 6 – Utilidad clínica de los estudios moleculares en los adenomas hipofisarios

  2015cites this paper
• Down-regulation of Zac1 gene expression in rat white adipose tissue by androgens.

  2014cites this paper
• Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

  2014cites this paper
• Loss of heterozygosity at chromosome 6q23–25 correlates with clinical and histologic parameters in salivary gland adenoid cystic carcinoma

  2014cites this paper
• Plag 1 and Plagl 2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH 11

  2014cites this paper
• Novel pathway for somatostatin analogs in patients with acromegaly.

  2013cites this paper
• Genetics of pituitary adenomas.

  2013cites this paper
• Correction: ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas

  2013cites this paper
• Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas.

  2013cites this paper
• ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas

  2013cites this paper
• cooperation with Cbfb-MYH11 Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in

  2013cites this paper
• Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

  2013cites this paper
• Pituitary Tumors: Genetics and Heritable Predisposition

  2013cites this paper
• Somatostatin receptors: from signaling to clinical practice.

  2013cites this paper
• The human imprintome: regulatory mechanisms, methods of ascertainment, and roles in disease susceptibility.

  2012cites this paper
• Mutations d’AIP (Aryl hydrocarbon receptor-Interacting Protein)dans les adénomes hypophysaires sporadiques

  2012influential citation
• PI3K/Akt/mTOR and Raf/MEK/ERK signaling pathways perturbations in non-functioning pituitary adenomas

  2012influential citation
• Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.

  2012cites this paper
• Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas.

  2012cites this paper
• Intrauterine Growth Restriction (IUGR) and imprinted gene expression in the placenta: Role of PLAGL1 and analysis of the 6q24.2 Region

  2012cites this paper
• Epigenetic and Posttranscriptional Alterations of Tumor Suppressor Genes in Sporadic Pituitary Adenomas

  2012influential citation
• Tumor suppressor genes

  2012cites this paper
• Control of Retinal Development by Tumor Suppressor Genes

  2012cites this paper
• The molecular pathogenesis of pituitary tumors: implications for clinical management.

  2012cites this paper
• Tcf4 is a target gene of the imprinted gene Zac1 during mouse neurogenesis

  2012cites this paper
• Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.

  2012cites this paper
• Pituitary gland: New pathways in the pathogenesis of pituitary adenomas

  2012cites this paper
• RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells.

  2012cites this paper
• The pathology of pituitary adenomas from a clinical perspective.

  2011cites this paper
• Pathogenesis of pituitary tumors

  2011cites this paper
• PLAGL1 (pleomorphic adenoma gene-like 1)

  2011cites this paper
• Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors.

  2011cites this paper
• Zac1 plays a key role in the development of specific neuronal subsets in the mouse cerebellum

  2011cites this paper
• MicroRNAs in the Human Pituitary

  2011cites this paper
• Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas.

  2011cites this paper
• NOD proteins and their functional relevance to normal and adenomatous pituitary

  2010cites this paper
• Future Directions in Endocrine Pathology

  2010cites this paper
• Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis.

  2010cites this paper
• Functioning Pituitary Adenomas

  2010cites this paper
• Recent Developments in the Molecular Biology of Pituitary Tumors

  2010cites this paper
• The novel sumoylation enhancer RSUME is implicated in pituitary tumor pathogenesis

  2010cites this paper
• The somatostatin analogue octreotide confers sensitivity to rapamycin treatment on pituitary tumor cells.

  2010cites this paper
• Anterior pituitary adenomas: inherited syndromes, novel genes and molecular pathways

  2010cites this paper
• Viral induction of Zac1b through TLR3- and IRF3-dependent pathways.

  2010cites this paper
• The genetics of pituitary adenomas.

  2010cites this paper
• ZAC1 target genes and pituitary tumorigenesis.

  2010cites this paper
• Studies on the PI3K/mTOR pathway as cytostatic treatment target in pituitary adenomas

  2010influential citation
• Genetic factors in the development of pituitary adenomas.

  2010cites this paper
• Genomic imprinting syndromes and cancer.

  2010cites this paper
• Familial pituitary adenomas.

  2009cites this paper
• Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly

  2009influential citation
• [Classification and pathophysiology of pituitary adenomas].

  2009cites this paper
• Familial pituitary adenomas

  2009cites this paper
• Lot1 Is a Key Element of the Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)/Cyclic AMP Pathway That Negatively Regulates Neuronal Precursor Proliferation*

  2009cites this paper
• The pathophysiology of pituitary adenomas.

  2009cites this paper
• CANNABIS, UNA OPCIÓN TERAPÉUTICA

  2009cites this paper
• Classification et physiopathologie des adénomes hypophysaires

  2009cites this paper
• Predicting recurrence of nonfunctioning pituitary adenomas.

  2009cites this paper
• MicroRNAs and possible role in pituitary adenoma.

  2008cites this paper
• Tip60 modulates PLAGL2‐mediated transactivation by acetylation

  2008cites this paper
• Neonatal diabetes mellitus.

  2008cites this paper
• MicroRNAs and Possible Role in Pituitary Adenoma

  2008cites this paper
• Molecular Pathogenesis of Pituitary Adenomas

  2008cites this paper
• Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune–Albright syndrome, familial acromegaly and genetic defects in sporadic tumors

  2008cites this paper
• Angiocentric Glioma: Report of Clinico-Pathologic and Genetic Findings in 8 Cases

  2007cites this paper
• Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters.

  2007cites this paper
• Molecular alterations during insulinoma tumorigenesis.

  2007cites this paper
• DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients.

  2007cites this paper
• Preferential Loss of the Nonimprinted Allele for the ZAC1 Tumor Suppressor Gene in Human Capillary Hemangioblastoma

  2007cites this paper
• Molecular alterations during insulinoma tumorigenesis.

  2007cites this paper
• Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas

  2007cites this paper
• LOT1 (ZAC1/PLAGL1) and its family members: Mechanisms and functions

  2007influential citation
• Zac1 promotes a Müller glial cell fate and interferes with retinal ganglion cell differentiation in Xenopus retina

  2007cites this paper